Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin for Incompletely Recovered COPD Exacerbations
NCT02300220Phase 3Completed
- Sponsor
- Imperial College London
- Start
- May 2014
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ciprofloxacin in chronic obstructive pulmonary disease (COPD), sponsored by Imperial College London. Started May 2014; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02300220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02300220.